These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 625998)

  • 1. [Pharmacological treatment of pathological increases in muscle tonus].
    Reisner H
    Wien Med Wochenschr; 1978 Feb; 128(3):57-62. PubMed ID: 625998
    [No Abstract]   [Full Text] [Related]  

  • 2. Baclofen for spasticity.
    Drug Ther Bull; 1973 Aug; 11(6):63-4. PubMed ID: 4731234
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment of multiple sclerosis.
    Rudick RA; Schiffer RB; Herndon RM
    Semin Neurol; 1987 Jun; 7(2):150-9. PubMed ID: 2845549
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of MS spasticity.
    Pozzilli C
    Eur Neurol; 2014; 71 Suppl 1():1-3. PubMed ID: 24457845
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathecal baclofen therapy for spastic hypertonia.
    Ivanhoe CB; Tilton AH; Francisco GE
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):923-38, viii-ix. PubMed ID: 11727722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):187-94. PubMed ID: 1442217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-spasticity medications.
    Al-Shahrani AM
    Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of baclofen against placebo.
    Hudgson P; Weightman D; Cartlidge NE
    Postgrad Med J; 1972 Oct; 48():Suppl 5:37-40. PubMed ID: 4585729
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy: spasticity (second of two parts).
    Young RR; Delwaide PJ
    N Engl J Med; 1981 Jan; 304(2):96-9. PubMed ID: 7003385
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabis based drug is licensed for spasticity in patients with MS.
    Kmietowicz Z
    BMJ; 2010 Jun; 340():c3363. PubMed ID: 20570870
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptom management.
    O'Connor P
    Adv Neurol; 2006; 98():227-55. PubMed ID: 16400837
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A breakthrough for the treatment of spasticity in multiple sclerosis].
    Lebrun C; Vermersch P
    Rev Neurol (Paris); 2015 Apr; 171(4):327-8. PubMed ID: 25835097
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscle relaxants in multiple sclerosis.
    Basmajian JV
    Int Disabil Stud; 1987; 9(2):90-1. PubMed ID: 3680109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.
    Haselkorn JK; Balsdon Richer C; Fry Welch D; Herndon RM; Johnson B; Little JW; Miller JR; Rosenberg JH; Seidle ME;
    J Spinal Cord Med; 2005; 28(2):167-99. PubMed ID: 15889701
    [No Abstract]   [Full Text] [Related]  

  • 18. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetometric demonstration of the antispastic action of a GABA derivative (Ciba 34647-BA)].
    Mutani R; Fariello R; Quattrocolo G; Delsedime M
    Riv Neurol; 1971; 41(3):143-51. PubMed ID: 5126431
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional outcome after delivery of intrathecal baclofen.
    Parke B; Penn RD; Savoy SM; Corcos D
    Arch Phys Med Rehabil; 1989 Jan; 70(1):30-2. PubMed ID: 2916915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.